FDA Inspection 872735 — Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd

Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd — FEI 3008259952

The FDA completed an inspection of Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd on March 13, 2014 in Jinhua. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 13, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jinhua (China)